Ozempic, medically termed “semaglutide” is a medication for diabetes and weight management. Recently, researchers have found its potential to help curb addiction cravings as well. While in development, it’s worth understanding its possibilities for your addictive behaviors.
If you’re interested in learning about this new medication that could possibly help with your substance use disorder, let’s dive in.
It is an approved medication for type 2 diabetes and weight loss.
For diabetes, this drug activates the hormonal pathways in your body to stimulate insulin release from your pancreas. This regulates your blood sugar levels when they’re on high. It also signals your liver to reduce the glucose it produces to maintain blood sugar levels during the day.
Additionally, it slows down the rate at which food goes through your stomach. This reduces your appetite and promotes weight loss.
This drug targets your glucagon-like peptide-1 (GLP-1) system. This plays a crucial role in regulating your blood sugar levels and appetite. When you take this drug, your GLP-1 receptors are activated, allowing increased insulin secretion and decreased glucagon secretion.
However, GLP-1 also affects areas of your brain involved in reward pathways and appetite regulation. When the drug mirrors this, it decreases your cravings, keeps you satisfied, and reduces your desire for food. That’s why it works for weight loss.
But this is also the reason behind its consideration for managing addiction cravings.
Source: Pexels
Due to the effects of Ozempic on the reward pathways, several scientists have deduced the potential to use the drug to curb drinking and drug behavior.
The most prominent theory regarding the link between Ozempic and addiction is that GLP-1 receptors are also present in several brain regions.
For example, GLP-1 can be found in a brain region called the mesolimbic system. This is integral to your reward pathways and could alter your dopamine release. Recall that dopamine is one of the key neurotransmitters involved in addiction. The theory is that activating GLP-1 could influence your brain activities surrounding reward and pleasure. The ideal conclusion is that it would reduce cravings and addictive behaviors.
Another rising theory is that these medications could modify your brain’s stress response systems. GLP-1 receptors can influence the regions in your brain that increase and modulate stress. Regulating these symptoms could potentially decrease your physiological and psychological stress responses, thus also potentially reducing the likelihood of relapse. The idea is your brain would default to other coping mechanisms, instead of giving in to addictive behaviors.
This also implies the potential to reduce the chances of addiction in the first place.
Several studies have looked into the effects of GLP-1 agonists on addiction in both animal and preliminary human trials.
Animal trials have produced promising results, showing that GLP-1 agonists can reduce drug-seeking behavior in animals. Studies have also shown that Ozempic can decrease the rewarding effects of addictive substances. This has been particularly observed in rats exposed to heroin.
In human trials, early findings suggest effects on reducing cravings for substances like alcohol and cocaine. However, translating animal studies to human ones proves to be difficult.
Source: Pacific Crest Trail Detox
While the preliminary studies may be promising, there are still some challenges that Ozempic has to undergo before being safe for use.
It is difficult to deny the promising theoretical frameworks and preliminary studies of Ozempic for addiction cravings. However, it’s crucial to acknowledge the lack of clinical trials in humans. Despite promising results in animal research and early human trials, it is not enough.
Scientists still have to perform trials for long-term medication. Above all, the mechanism of the drug for addiction still requires a lot of studies. Until then, the drug will not be identified as safe and effective for managing substance use disorders.
Since GLP-1 agonists are currently used to treat diabetes, there are potential risks for those who are not diagnosed with it. Among these potential risks include hypoglycemia, especially for those who are not taking glucose-lowering medications.
Ozempic also carries the risk of side effects. Common side effects include nausea, vomiting, diarrhea, and constipation.
It’s important to note that due to studies still undergoing, Ozempic is not FDA-approved for treating addiction.
That said, your healthcare providers must be making both regulatory and ethical considerations if they ever prescribe you off-label medications.
While this drug may have theoretical benefits to curb addiction cravings, there are numerous ethical concerns to consider.
Ozempic may be promising for managing addictive behaviors, but recommending it to patients requires a balance of nonmaleficence and autonomy. You must understand that there is no clear evidence supporting the efficacy and safety of the drug as an addiction treatment. This must be explained to you before professionals ask for your consent. And at the end of the day, remember that taking this medication off-label must be your choice. Otherwise, it raises concerns regarding medical ethics.
On top of this, your healthcare providers must shy away from exposing you to unnecessary harm or false hope. They should not exclude the risks when they inform you of its potential.
Prescribing Ozempic for the unapproved use of addiction treatment poses challenges in monitoring and managing your side effects as well. This is particularly crucial if you have a complex medical history or have additional complications.
Along with your informed consent, your healthcare providers must weigh the potential benefits and risks of using Ozempic for your addiction. This must be based on your specific needs, preferences, and medical history.
Source: Freepik
The potential of Ozempic for addiction management brings both promise and caution. While scientific theories suggest potential due to the connected pathways, it’s more important to understand that this theory is developing. A lot of research must be done before the efficacy and safety of it for addiction can be confirmed.
As the news of this drug spreads across the community, your healthcare providers must emphasize medical ethics and patient autonomy. Addiction treatment is a growing science, and you have the right to know about all the medications and processes you may undergo during your recovery.
In the meantime, contact Pacific Crest Trail Detox if you're looking to learn more about evidence-based medications!